{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T08:33:40Z","timestamp":1648974820573},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,4,11]],"date-time":"2007-04-11T00:00:00Z","timestamp":1176249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1007\/s00108-007-1843-8","type":"journal-article","created":{"date-parts":[[2007,4,10]],"date-time":"2007-04-10T03:56:03Z","timestamp":1176177363000},"page":"1157-1164","source":"Crossref","is-referenced-by-count":1,"title":["Benigne Prostatahyperplasie"],"prefix":"10.1007","volume":"48","author":[{"given":"S.","family":"Madersbacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Marszalek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,11]]},"reference":[{"key":"1843_CR1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0302-2838(03)00367-1","volume":"44","author":"Barkin","year":"2003","unstructured":"Barkin J, Guimaraes M, Jacobi G et al. (2003) Alpha-blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5\u03b1-reductase inhibitor dutasteride. Eur Urol 44: 461\u2013466","journal-title":"Eur Urol"},{"key":"1843_CR2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa053085","volume":"354","author":"Bent","year":"2006","unstructured":"Bent S, Kane C, Shinohara K et al. (2006) Saw palmetto for benign prostatic hyperplasia. N Engl J Med 354: 557\u2013566","journal-title":"N Engl J Med"},{"key":"1843_CR3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2004.05.008","volume":"46","author":"Debruyne","year":"2004","unstructured":"Debruyne F, Barkin J, Erps P van et al. (2004). Efficacy and safety of long-term treatment with the dual 5\u03b1-reducatse inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia. Eur Urol 46: 488\u2013495","journal-title":"Eur Urol"},{"key":"1843_CR4","first-page":"2","volume":"Urol","author":"Emberton","year":"2003","unstructured":"Emberton M (2003) The hallmarks of BPH progression and risk factors. Eur Urol (Suppl 8) 2: 2\u20137","journal-title":"Eur"},{"key":"1843_CR5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-5347(01)63011-8","volume":"160","author":"Flanigan","year":"1998","unstructured":"Flanigan RC, Reda DJ, Wasson JH et al. (1998) 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia. A department of Veterans Affairs Cooperative Study. J Urol 160: 12\u201317","journal-title":"J Urol"},{"key":"1843_CR6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0090-4295(02)02114-3","volume":"61","author":"Kirby","year":"2003","unstructured":"Kirby RS, Roehrborn C, Boyle P et al. (2003) Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of of symptomatic of symptomatic benign prostatic hyperplasia. The Prospective European DoxazosIn and Combination Therapy (PREDICT) trial. Urology 61: 119\u2013126","journal-title":"Urology"},{"key":"1843_CR7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199608223350801","volume":"335","author":"Lepor","year":"1996","unstructured":"Lepor H, Williford WO, Barry MJ et al. (1996) Veterans Affairs Cooperative Studies, benign prostatic hyperplasia study group. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. N Engl J Med 335: 533\u2013539","journal-title":"N Engl J Med"},{"key":"1843_CR8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000019699","volume":"34","author":"Madersbacher","year":"1998","unstructured":"Madersbacher S, Haidinger G, Temml C et al. (1998) The prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2096 men. Eur Urol 34: 136\u2013141","journal-title":"Eur Urol"},{"key":"1843_CR9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.eururo.2004.07.016","volume":"46","author":"Madersbacher","year":"2004","unstructured":"Madersbacher S, Alivizatos G, Nordling J et al. (2004) EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46: 547\u2013554","journal-title":"Eur Urol"},{"key":"1843_CR10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00120-005-0778-8","volume":"44","author":"Madersbacher","year":"2005","unstructured":"Madersbacher S, Schatzl G, Broessner C et al. (2005) Phytotherapy for BPS: which products can still be prescribed? Urologe A 44: 513\u2013520","journal-title":"Urologe A"},{"key":"1843_CR11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM199802263380901","volume":"338","author":"McConnell","year":"1998","unstructured":"McConnell JD, Bruskewitz R, Walsh P et al. (1998) The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med 338: 557\u2013563","journal-title":"N Engl J Med"},{"key":"1843_CR12","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","volume":"349","author":"McConnell","year":"2003","unstructured":"McConnell JD, Roehborn CG, Bautista OM et al. (2003). The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349: 2387\u20132398","journal-title":"N Engl J Med"},{"key":"1843_CR13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0090-4295(02)01905-2","volume":"60","author":"Roehborn","year":"2002","unstructured":"Roehborn CG, Boyle P, Nickel JC et al. (2002) Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 60: 434\u2013441","journal-title":"Urology"},{"key":"1843_CR14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00120-004-0712-5","volume":"43","author":"Schneider","year":"2004","unstructured":"Schneider T, R\u00fcbben H (2004) Extract of stinging nettle roots (Bazoton-uno) in long-term treatment of benign prostatic syndrome (BPS). Results of a randomized, double blind, placebo-controlled multicentre study after 12 months. Urologe A 43: 302\u2013306","journal-title":"Urologe A"},{"key":"1843_CR15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0302-2838(03)00084-8","volume":"43","author":"Temml","year":"2003","unstructured":"Temml C, Broessner C, Schatzl G et al. (2003) The natural history of lower urinary tract symptoms over 5 years. Eur Urol 43: 374\u2013380","journal-title":"Eur Urol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1843-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-007-1843-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1843-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:11:41Z","timestamp":1558570301000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-007-1843-8"}},"subtitle":["Erfolge und Grenzen der Pharmakotherapie"],"short-title":[],"issued":{"date-parts":[[2007,4,11]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["1843"],"URL":"https:\/\/doi.org\/10.1007\/s00108-007-1843-8","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,11]]}}}